TEXTBOOK OF Cancer in Pregnancy


INCIP is a network established under the auspices of ESGO (European Society of Gynaecological Oncology) and aims to promote research on cancer in pregnancy. Currently, the network counts 109 members from 34 countries that cooperate together, and established an international registry on cancer during pregnancy and fertility preservation.

INCIP also studies the effects of various cancer therapies of both mother and a child. Since it is counterintuitive to administer drugs that are designed to kill rapidly dividing cells to pregnant women, core in this project is the documentation of health and development in the offspring. Our results however show that the children perform as well as other children of the same gender and age. Adverse effects are more likely to occur as a consequence of premature birth than of cancer treatment during pregnancy. Together with other studies, INCIP data show the potential to treat cancer during pregnancy. The reassuring data allow a shift of the paradigm that termination of pregnancy or a medically induced preterm delivery is mandatory. Instead, we now observe a clear trend towards fewer terminations of pregnancy, more cancer treatment during pregnancy. Also, children are less likely to be born preterm. In the years to come, INCIP aims to refine the conclusions and confirm them in longer-term studies. In addition, the maternal prognosis in these cases remains our focus. Our network provides also an opportunity to invest in the study for fertility-sparing cancer treatments.

We are glad to share our findings with you in this new Textbook Cancer in Pregnancy and hope that the information can be clinically useful for colleagues all over the world.

Get your hard copy now

Editor in Chief Frederic Amant and 57 Editors


General Management Of Cancer & Pregnancy

  • Epidemiology
  • Imaging During Pregnancy
  • Radiotherapy During Pregnancy
  • Surgery During Pregnancy
  • Targeted -, Hormonal -, Immunotherapy
  • Chemotherapy During Pregnancy
  • Supportive Therapy
  • Gpsychological Challenges And Support For Pregnant Women Diagnosed With Cancer And Their Family
  • Obstetrical Management
  • Pediatric Long-Term Outcome After In Utero Exposure To Cancer Treatment
  • National And International Organisation Of Cancer In Pregnancy Research And Clinical Care

Specific Cancers During Pregancy

  • Breast Cancer
  • Cervical Intraepithelial Neoplasia (Cin)
  • Cervical Cancer
  • Invasive Ovarian Cancer
  • Borderline Ovarian Tumour
  • Acute Leukemia During Pregnancy
  • Hodgkin Lymphoma And Non-Hodgkin Lymphoma
  • Melanoma
  • Gastro-Intestinal Cancer
  • Thyroid Cancer
  • Brain Tumours In Pregnancy

Fertility Sparing Management

  • Surgical Aspects
  • Preventive Strategies During Radio – And/Or Chemotherapy
  • Preventive Strategies Before Radioand/Or Chemotherapy – Oocyte And Ovarian

Directly to:

ESGO Newsletter

Get notified on all news and activities right in your mailbox.

Upcoming events

ESGO 2018 294X170


ESGO State of the Art 
October 4-6, 2018 
Lyon, France

Save the Date!

Read More

banner web 194x170

Surgery Course

Ovarian Cancer Surgery Course
December 6 – 8, 2018 
Hamburg, Germany


Read More



  ESGO 2019 Athens Congress

November 2-5, 2019

Athens, Greece

Save the Date!

Read More


European Society of Gynaecological Oncology

The European Society of Gynaecological Oncology (ESGO) is the leading European organisation with more than 2,500 professionals involved in treatment, care and research of gynaecologic cancers.

Contact us





News Updates

Get notified on all of ESGO’s news and activities.

Sign-up Now!